Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Clonidine recalled?

Yes — there is an active recall. 4 ongoing FDA recalls mention Clonidine (92 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Clonidine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Clonidine recalls on record

none so far in 2026; 92 on record, newest first
Class II · Moderate risk

Clonidine HCL PF 750 mcg/mL/Prialt PF

Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.

Terminated cGMP deviation Coast Quality Pharmacy, LLC dba Anazao Health D-0598-2020
Class II · Moderate risk

Clonidine HCL and Baclofen in all strengths

Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.

Terminated cGMP deviation Coast Quality Pharmacy, LLC dba Anazao Health D-0596-2020
Class II · Moderate risk

Clonidine HCL in all strengths

Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.

Terminated cGMP deviation Coast Quality Pharmacy, LLC dba Anazao Health D-0595-2020
Class III · Low risk

Clonidine HCL Injection

Labeling: Label Error on Declared Strength: Side carton panel incorrectly lists the concentration as "500 mcg Clonidine Hydrochloride" rather than the correct concentration of "100 mcg Clonidine Hydrochloride" per mL.

Terminated Labeling / mix-up X-Gen Pharmaceuticals Inc. NDC 39822-2000-1 D-1084-2019
Class II · Moderate risk

Catapres .2

Failed Dissolution Specifications: OOS resultsduring routine stability testing

Terminated Dissolution failure Boehringer Ingelheim Pharmaceuticals, Inc. NDC 0597-0007-01 D-0128-2019
Class II · Moderate risk

Clonidine HCl USP for prescription compounding

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Terminated Stability / shelf life American Pharmaceutical Ingredients LLC NDC 58597-8010-2 D-0480-2018
Class II · Moderate risk

Clonidine Hydrochloride Tablets

cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product, was dispensed in unauthorized rooms by the drug substance manufacturer

Terminated cGMP deviation Mutual Pharmaceutical Company, Inc. NDC 53489-217-01 D-1282-2015
Class II · Moderate risk

Clonidine Hydrochloride Tablets

cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product, was dispensed in unauthorized rooms by the drug substance manufacturer

Terminated cGMP deviation Mutual Pharmaceutical Company, Inc. NDC 53489-216-01 D-1281-2015
Class II · Moderate risk

Clonidine Hydrochloride Tablets

cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product, was dispensed in unauthorized rooms by the drug substance manufacturer

Terminated cGMP deviation Mutual Pharmaceutical Company, Inc. NDC 53489-215-01 D-1280-2015